Cencora, Inc.
CORNYSEHealthcare● Active
$275.04
+$4.72(+1.75%)
Market Cap$53.5B
P/E Ratio—
52W High$377.54
52W Low$244.82
Cencora, Inc. (COR) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
COR · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: May 6, 2026EPS Actual
$4.75
Est. $4.82 · -1.4%
Revenue
$78.36B
Est. $81.09B · -3.4%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 6, 2026
After Market Close
▼ Miss EPS▼ Miss Revenue
COR reports quarterly as a NYSE-listed Medical - Distribution company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$0.37
Rev. $0.36B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$0.37
Rev. Est.$0.36B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 5, 2026 | $4.37 | — | — | — | $84.36B | — |
| ▼ Q2 FY2026 | May 6, 2026 | $4.82 | $4.75 | -1.4% | $78.36B | $81.09B | -3.4% |
| — Q1 FY2026 | Feb 4, 2026 | $4.05 | $4.08 | +0.7% | $85.93B | $86.06B | -0.1% |
| ▲ Q4 FY2025 | Nov 5, 2025 | $3.79 | $3.84 | +1.3% | $83.73B | $83.46B | +0.3% |
| ▲ Q3 FY2025 | Aug 6, 2025 | $3.85 | $4.00 | +3.9% | $80.66B | $80.09B | +0.7% |
| ▲ Q2 FY2025 | May 7, 2025 | $4.11 | $4.42 | +7.5% | $75.45B | $75.68B | -0.3% |
| ▲ Q1 FY2025 | Feb 5, 2025 | $3.50 | $3.73 | +6.6% | $81.49B | $78.31B | +4.1% |
| ▲ Q4 FY2024 | Nov 6, 2024 | $3.23 | $3.34 | +3.4% | $79.05B | $77.62B | +1.8% |
Q3 FY2026
Aug 5, 2026
EPS Actual
—
EPS Est.
$4.37
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 6, 2026Miss
EPS Actual
$4.75
EPS Est.
$4.82
EPS Surpr.
-1.4%
Revenue
$78.36B
Q1 FY2026
Feb 4, 2026
EPS Actual
$4.08
EPS Est.
$4.05
EPS Surpr.
+0.7%
Revenue
$85.93B
Q4 FY2025
Nov 5, 2025Beat
EPS Actual
$3.84
EPS Est.
$3.79
EPS Surpr.
+1.3%
Revenue
$83.73B
Q3 FY2025
Aug 6, 2025Beat
EPS Actual
$4.00
EPS Est.
$3.85
EPS Surpr.
+3.9%
Revenue
$80.66B
Q2 FY2025
May 7, 2025Beat
EPS Actual
$4.42
EPS Est.
$4.11
EPS Surpr.
+7.5%
Revenue
$75.45B
Q1 FY2025
Feb 5, 2025Beat
EPS Actual
$3.73
EPS Est.
$3.50
EPS Surpr.
+6.6%
Revenue
$81.49B
Q4 FY2024
Nov 6, 2024Beat
EPS Actual
$3.34
EPS Est.
$3.23
EPS Surpr.
+3.4%
Revenue
$79.05B
Analyst Estimates
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q3 FY2029 | $5.49 | $5.61 | $5.72 | 3 |
| Q2 FY2029 | $5.58 | $5.70 | $5.81 | 5 |
| Q1 FY2029 | $6.38 | $6.52 | $6.65 | 3 |
| Q4 FY2028 | $5.29 | $5.41 | $5.51 | 7 |
| Q3 FY2028 | $5.84 | $5.97 | $6.08 | 4 |
| Q2 FY2028 | $5.52 | $5.64 | $5.75 | 6 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q3 FY2029 | $116B | $118B | $120B | 4 |
| Q2 FY2029 | $108B | $110B | $112B | 4 |
| Q1 FY2029 | $102B | $104B | $106B | 5 |
| Q4 FY2028 | $110B | $112B | $113B | 2 |
| Q3 FY2028 | $98.0B | $99.7B | $101B | 2 |
| Q2 FY2028 | $93.4B | $95.0B | $96.4B | 2 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q2 FY2026 | May 6, 2026 | -1.4% | $305.90 | $252.74 | -17.38% |
| ▲ Q1 FY2026 | Feb 4, 2026 | +0.7% | $361.75 | $329.97 | -8.79% |
| ▲ Q4 FY2025 | Nov 5, 2025 | +1.3% | $344.53 | $354.00 | +2.75% |
| ▲ Q3 FY2025 | Aug 6, 2025 | +3.9% | $292.35 | $283.78 | -2.93% |
| ▲ Q2 FY2025 | May 7, 2025 | +7.5% | $290.81 | $304.58 | +4.74% |
| ▲ Q1 FY2025 | Feb 5, 2025 | +6.6% | $251.57 | $253.28 | +0.68% |
| ▲ Q4 FY2024 | Nov 6, 2024 | +3.4% | $233.99 | $245.38 | +4.87% |
| ▲ Q3 FY2024 | Jul 31, 2024 | +3.7% | $231.03 | $237.88 | +2.96% |
Q2 FY2026-17.38%
Report Date
May 6, 2026
EPS Beat/Miss
-1.4%
Price Before
$305.90
Price After
$252.74
Q1 FY2026-8.79%
Report Date
Feb 4, 2026
EPS Beat/Miss
+0.7%
Price Before
$361.75
Price After
$329.97
Q4 FY2025+2.75%
Report Date
Nov 5, 2025
EPS Beat/Miss
+1.3%
Price Before
$344.53
Price After
$354.00
Q3 FY2025-2.93%
Report Date
Aug 6, 2025
EPS Beat/Miss
+3.9%
Price Before
$292.35
Price After
$283.78
Q2 FY2025+4.74%
Report Date
May 7, 2025
EPS Beat/Miss
+7.5%
Price Before
$290.81
Price After
$304.58
Q1 FY2025+0.68%
Report Date
Feb 5, 2025
EPS Beat/Miss
+6.6%
Price Before
$251.57
Price After
$253.28
Q4 FY2024+4.87%
Report Date
Nov 6, 2024
EPS Beat/Miss
+3.4%
Price Before
$233.99
Price After
$245.38
Q3 FY2024+2.96%
Report Date
Jul 31, 2024
EPS Beat/Miss
+3.7%
Price Before
$231.03
Price After
$237.88
Avg Beat Reaction+0.61%
Avg Miss Reaction-17.38%
Beat Rate7 / 8 quarters
Largest Move-17.38% (Q2 FY2026)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: COR ends December
Cencora, Inc. (COR) most recently reported earnings on May 6, 2026 for Q2 FY2026, posting EPS of $4.75 — missing the analyst consensus of $4.82 by -1.4%. The next COR earnings date is expected around September 1, 2026.
Each quarter, investors track COR earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. COR revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
COR's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
COR earnings · 5 questionsCencora, Inc.'s next earnings report is expected around September 1, 2026. COR typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; COR historically reports after market close (AMC).
COR earnings datewhen is COR earningsCOR next earnings datewhen does COR report earningsCOR earnings calendar
▸ Source: FMP · Cencora, Inc. SEC filings · US GAAP · Cencora, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026